INGN Share Price Performance
US$0
-7.55 (-100.00%)
Price US$0
Fair ValueUS$12.00
Share Pricen/a
Analysis Article • Aug 09
Inogen, Inc. Stock Price
- 3 Narratives written by author
- 2 Comments on narratives written by author
- 10 Fair Values set on narratives written by author
INGN Community Narratives
AN
Fair Value
·Fair Value US$12 52.4% undervalued intrinsic discount
Pricing Pressures And Rivals Will Erode Portable Oxygen Margins
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value
·Fair Value US$12.67 54.9% undervalued intrinsic discount
INGN: Profit Margins Will Strengthen Amid Broader Respiratory Care Market Expansion
0users have liked this narrative
2users have commented on this narrative
5users have followed this narrative
AN
Fair Value
·Fair Value US$14 59.2% undervalued intrinsic discount
Aging Global Population And At-Home Care Will Boost Market Demand
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Pricing Pressures And Rivals Will Erode Portable Oxygen Margins
Inogen sells portable oxygen devices, but tougher price pressure and a wave of low-cost rivals could turn these products into commodities, squeezing profits and slowing growth. At the same time, a growing need for portable oxygen, new product launches, and connected features could still give the company room to rebound if it executes well.Read more
AN
US$12
52.4% undervalued intrinsic discount
Fair Value
Profit Margin
12.11%
Future PE
7.96x
Price in 2029
US$14.86
INGN: Profit Margins Will Strengthen Amid Broader Respiratory Care Market Expansion
Key Takeaways Growing demand for home respiratory care and a diversifying product portfolio position the company for sustained market expansion and top-line growth. Digital integration, operational optimization, and new product innovation are driving higher margins, recurring revenue, and support for long-term earnings growth.Read more
AN
US$12.67
54.9% undervalued intrinsic discount
Fair Value
Profit Margin
12.11%
Future PE
8.54x
Price in 2029
US$15.67
Aging Global Population And At-Home Care Will Boost Market Demand
Key Takeaways Portfolio expansion with bundled oxygen solutions and new product launches positions Inogen for sustained, accelerated growth and broader market leadership. Integration of digital health and international expansion supports higher customer value, recurring high-margin revenue, and substantial long-term profit potential.Read more
AN
US$14
59.2% undervalued intrinsic discount
Fair Value
Profit Margin
12.32%
Future PE
11.21x
Price in 2028
US$14.54
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
INGN: Bullish Initiation And New CFO Will Support Future Upside
Fair Value: US$12 52.4% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
INGN: Bullish Initiation And Buyback Program Will Support Future Upside
Fair Value: US$12.67 54.9% undervalued intrinsic discount
5 fair values setusers have set this as their fair value
2 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Aging Global Population And At-Home Care Will Boost Market Demand
Fair Value: US$14 59.2% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Inogen, Inc. Key Details
About INGN
- Founded
- 2001
- Employees
- 753
- CEO
- WebsiteView website
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.
